Orchid Pharma Ltd Quarterly Results

Gross Sales

217.34

222.7

244.41

217.1

220.59

Excise Duty

0

0

0

0

0

Net Sales

217.34

222.7

244.41

217.1

220.59

Other Operating Income

0

0

0

0

0

Other Income

8.49

7.52

7.57

13.36

7.62

Total Income

225.83

230.22

251.98

230.46

228.21

Total Expenditure

190.98

192.36

211.91

188.18

185.2

PBIDT

34.85

37.85

40.06

42.28

43.01

Interest

3.8

3.33

3.5

3.47

3.54

PBDT

31.06

34.53

36.56

38.8

39.46

Depreciation

8.61

8.63

8.44

8.42

9.27

Minority Interest Before NP

0

0

0

0

0

Tax

0

0

-0.15

0.11

0

Deferred Tax

0

0

0

-3.23

0

Reported Profit After Tax

22.45

25.9

28.27

33.5

30.19

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

20.78

27.24

29.35

32.96

29.43

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

20.78

27.24

29.35

32.96

29.43

EPS (Unit Curr.)

4.1

5.37

5.79

6.81

6.18

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

50.72

50.72

50.72

50.72

50.72

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

16.03

16.99

16.39

19.47

19.49

PBDTM(%)

14.29

15.5

14.95

17.87

17.88

PATM(%)

10.32

11.62

11.56

15.43

13.68